Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
09/2010
09/01/2010EP2222304A2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
09/01/2010EP2057122B1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor
09/01/2010EP1854787B1 Novel cyclic compound having quinolylalkylthio group
09/01/2010EP1635839B1 Benzo[4,5]thieno[2,3-d]pyrimidin-4-ones and their use in therapy
09/01/2010EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/01/2010EP1408117B1 Glycoprotein and process for producing the same
09/01/2010EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
09/01/2010CN201564666U Therapeutic apparatus for preventing and curing myopia and for curing presbyopia
09/01/2010CN1969855B Pharmaceutical composition having target organ protection function and usage thereof
09/01/2010CN101816655A Medicinal preparation containing repaglinide and ligustrazine and application thereof in diabetic complications
09/01/2010CN101147726B Good stability chloromycetin eyedrop and preparation method thereof
09/01/2010CN101095939B Eyedrops and method for preparing the same
08/2010
08/31/2010US7786311 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/31/2010US7786100 Composition and method of treating hearing loss
08/31/2010US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
08/31/2010US7785870 Cell-specific expression/replication vector
08/31/2010US7785599 Albumin fusion proteins
08/31/2010CA2447779C Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
08/26/2010WO2010095663A1 Fused heterocyclic ring compound
08/26/2010WO2010095478A1 Sustainedly drug-releasing hydrogel contact lens, and drug releasing method using sustainedly drug-releasing hydrogel contact lens
08/26/2010WO2010095462A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same
08/26/2010WO2010080563A3 Method for treating macular degeneration
08/26/2010WO2010076524A3 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
08/26/2010WO2010004435A9 Ph specific solutions of sodium mycophenolic acid for the treatment of eye disorders
08/26/2010WO2009109501A3 Ocular pharmaceutical compositions
08/26/2010WO2009090085A8 Abnormal intraocular pressure treatment
08/26/2010US20100216886 Polymorphs of n2-(1,1'-biphenyl-4-ylcarbonyl)-n1-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha-glutamine
08/26/2010US20100216882 Aspirin-triggered lipid mediators
08/26/2010US20100216877 Storage Stable Prostaglandin Product
08/26/2010US20100216871 Use of compounds having ccr antagonism
08/26/2010US20100216865 MicroRNA COMPOSITIONS IN THE TREATMENT OF VEGF-MEDIATED DISORDERS
08/26/2010US20100216859 Curcumin analog compositions and related methods
08/26/2010US20100216856 Protective agent for retinal nerve or optic nerve
08/26/2010US20100216840 Benzimidazolidinone derivatives as muscarinic agents
08/26/2010US20100216820 Thienopyrimidiones for treatment of inflammatory disorders and cancers
08/26/2010US20100216818 Inhibitors of Post-Amadori Advanced Glycation End Products
08/26/2010US20100216799 Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists
08/26/2010US20100216789 Rho-kinase inhibitors
08/26/2010US20100216787 Thiazole derivative
08/26/2010US20100216786 New compounds
08/26/2010US20100216785 Pharmaceutical compositions
08/26/2010US20100216777 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
08/26/2010US20100216741 Ophthalmic composition
08/26/2010US20100216700 Methods of treating ocular disorders
08/26/2010US20100215759 Pharmaceutical compounds
08/26/2010US20100215746 Prevention of cisplatin induced deafness
08/26/2010US20100215741 Pharmaceutical compounds
08/26/2010US20100215720 Implantable optical system, method for developing it and applications
08/26/2010US20100215717 Endothelial scaffolds
08/26/2010US20100215710 Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing
08/26/2010US20100215676 Kdr peptides and vaccines comprising the same
08/26/2010US20100215667 Methods and compositions of treatment for modulating the immune system of animals
08/26/2010US20100215666 Il-17 antagonistic antibodies
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215657 Methods and Compositions Using Klotho-FGF Fusion Polypeptides
08/26/2010US20100215655 Angiogenesis-inhibiting chimeric proteins and the use
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215646 Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo) containing different lengths of palindromic segments
08/26/2010US20100215640 Method for inhibiting cellular activation by insulin-like growth factor-1
08/26/2010US20100215621 Recombinant Adenoviruses Capable Of Regulating Angiogenesis
08/26/2010US20100215614 Enterostatin as Inhibitor of Angiogenesis
08/26/2010CA2753106A1 Hydrogel contact lens for sustained drug release and drug release method using hydrogel contact lens for sustained drug release
08/26/2010CA2752679A1 Isolated monocyte populations and related therapeutic applications
08/25/2010EP2221377A1 Oligonucleotide compositions with enhanced efficiency
08/25/2010EP2221301A1 Heteroaryloxy quinazoline derivative
08/25/2010EP2221054A1 CDK inhibitors for lowering intraocular pressure
08/25/2010EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
08/25/2010EP2220057A2 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions
08/25/2010EP2220052A1 Cyclic urea inhibitors of 11 -hydroxysteroid dehydrogenase 1
08/25/2010EP2219634A1 Pharmaceutical for the treatment of phantom phenomena
08/25/2010EP1719517B1 Artificial physiological salt solution and process for producing the same
08/25/2010EP1480627B1 Methods of reducing angiogenesis
08/25/2010EP1474109B1 Use of synthetic inorganic nanoparticles as carriers for ophthalmic drugs
08/25/2010EP1363632B1 Receptor selective cannabimimetic aminoalkylindoles
08/25/2010EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors
08/25/2010EP1263722B1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
08/25/2010EP1263721B1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
08/25/2010CN101815700A Derivatives of 4-(2-amino-1 -hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
08/25/2010CN101815513A Ophthalmic formulation containing paracetamol
08/25/2010CN101812190A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
08/25/2010CN101812189A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
08/25/2010CN101812122A Protection effect of light-harvesting chromoprotein of algae on lens epithelial cells
08/25/2010CN101812008A IDO inhibitor containing pyrrole-2-aryl structure and preparation method thereof
08/25/2010CN101810772A Chinese medicament for curing sudden deafness and tinnitus
08/25/2010CN101810629A Composition injection of glycerol and fructose and preparation method thereof
08/25/2010CN101810567A Small molecular group water eye drops
08/25/2010CN101810563A Tacrolimus ophthalmic in-situ gel preparation and preparation method thereof
08/25/2010CN101209322B 'Chuierbaoting' powder
08/25/2010CN101041626B Tetrafluorobenzyl derivatives and pharmaceutical composition containing same
08/24/2010US7781440 Neurodegenerative diseases caused by GSK3 such as Alzheimer's disease
08/24/2010CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/24/2010CA2458468C Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
08/24/2010CA2445386C Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same
08/19/2010WO2010093873A2 Drug delivery through hydrogel plugs
08/19/2010WO2010093816A2 Gene therapy vector for treatment of steroid glaucoma
08/19/2010WO2010093209A2 Use of caveolin-1 as biomarker diagnosing wound healing ability after ophthalmological surgery and method for diagnosing wound healing ability using the same
08/19/2010WO2010092041A1 [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
08/19/2010WO2010056985A9 Treatment of proteinopathies using a farnesyl transferase inhibitor
08/19/2010WO2010045276A3 Azabenzimidazolones
08/19/2010WO2009135581A3 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
1 ... 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 ... 531